Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard O'brien

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cell Transplantation|September 5, 2017
Article RetractionWayne A Morrison, Bernard O'brien
American Heart Journal|February 22, 2003
Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) studyStuart J Connolly, Irene Cybulsky, André Lamy, et al.
American Heart Journal|June 20, 2006
Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trialWilliam S Weintraub, Paul Barnett, Shuo Chen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cell Transplantation|September 5, 2017
Article RetractionWayne A Morrison, Bernard O'brien
American Heart Journal|February 22, 2003
Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) studyStuart J Connolly, Irene Cybulsky, André Lamy, et al.
American Heart Journal|June 20, 2006
Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trialWilliam S Weintraub, Paul Barnett, Shuo Chen, et al.
Pageof 1